Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 6:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: HIV Infections, Pregnancy
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older · Female only
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 31
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 21 more

Conditions: Free Flap Reconstruction
Interventions: sufentanil, methadone; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Poor Glycemic Control
Interventions: Metformin, Glargine insulin, Glulisine; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Arthroplasty, Replacement, Knee, Total Knee Replacement
Interventions: X3 Polyethylene, N2Vac Polyethylene; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 85 Years
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2023
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Chronic Heart Failure
Interventions: RLX030 (serelaxin), Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 321 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 9
States / cities: Anaheim, California • Colorado Springs, Colorado • Jacksonville, Florida + 5 more

Conditions: Hypertension
Interventions: Optical Blood Pressure Monitoring Device (Aktiia G1); Device
Lead sponsor: Nucor; Industry
Eligibility: 25 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Von Willebrand Diseases
Interventions: Von Willebrand Factor-Containing Product; Drug
Lead sponsor: Octapharma; Industry
Eligibility: 66 Months and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cerebral Ischemia
Interventions: CDI 1000 COM; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Orange, California

Conditions: Trauma, Tumor, Pseudarthrosis, Scoliosis, Degenerative Disc Disease
Interventions: VueLock™ Anterior Cervical Plate; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: Not listed
Enrollment: 371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2009
U.S. locations: 4
States / cities: Palo Alto, California • San Diego, California • Avon, Indiana + 1 more

Conditions: Osteoarthrosis of the Carpometacarpal Joint of the Thumb
Interventions: casts for the thumb, Motion group; Other
Lead sponsor: University of Utah; Other
Eligibility: 40 Years to 80 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Gastroenterology, Lesions
Interventions: Endoscopic ultrasound- (EUS) guided tissue sampling; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Uterine Fibroid
Interventions: Bearing nsPVA; Device
Lead sponsor: Merit Medical Systems, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Traumatic Brain Injury
Interventions: SENSE device; Device
Lead sponsor: Sense Diagnostics, LLC; Industry
Eligibility: 22 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Gainesville, Florida • Cincinnati, Ohio • Pittsburgh, Pennsylvania + 3 more

Conditions: Urinary Retention, Urinary Bladder, Neurogenic, Intermittent Catheterization
Interventions: C3 "UMBRELLA CATHETER"; Device
Lead sponsor: Dr. Gaines W. Hammond Jr. MD FACS; Individual
Eligibility: 21 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Lakeland, Florida

Conditions: Supraglottic Airway
Interventions: AMBU Aura-I/aScope 2, LMA Fastrach Single Use; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Sacroiliitis, Sacroiliac Joint Dysfunction
Interventions: TransLoc 3D; Device
Lead sponsor: CornerLoc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Port Jefferson Station, New York

Conditions: Vitiligo
Interventions: Phototherapy, Phototherapy and Photochemotherapy; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Radius Fracture
Interventions: Early motion, Immobilization; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: PORTs/Peripheral IVs Complication Rates
Interventions: Not listed
Lead sponsor: C. R. Bard; Industry
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Quincy, Illinois • Shreveport, Louisiana

Conditions: Psoriasis (PsO)
Interventions: Deucravacitinib, Other systemic treatments for PsO; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: Female only
Enrollment: 900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Arthroplasty, Replacement, Knee
Interventions: Radiofrequency Ablation (RFA), Simulated Radiofrequency Ablation (RFA); Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia
Interventions: ABT-335, Rosuvastatin Calcium, Placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years and older
Enrollment: 1,445 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: North Chicago, Illinois

Conditions: Age-Related Macular Degeneration
Interventions: No intervention; Other
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 50 Years to 94 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 46
States / cities: Springdale, Arkansas • Encino, California • Fullerton, California + 40 more

Conditions: Opioid Use, Traumatic Injury, Adolescent Behavior, Substance Abuse Disorder
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 20 Years
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Search by objective public record fields.

A Study of HIV Levels During Pregnancy and After Childbirth

Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

X-3 Polyethylene Survival Outcomes Study

Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure

A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.

Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

Postoperative Rehabilitation Following Trapeziectomy and Ligament Reconstruction Tendon Interposition

Evaluation of Diagnostic Yield of EUS-Guided Tissue Sampling

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

A Study to Evaluate the SENSE Device's Ability to Detect TBI

A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter."

AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA

Post-Market Clinical Study on a Modular SI Joint Fusion System

NB-UVB and PUVA Vitiligo Study

Early Motion After Volar Fixation for Distal Radius Fractures

Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

A Study to Assess Deucravacitinib Safety in Pregnancy

Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Opioid Use After Traumatic Injury in Adolescents